Despina Drivakou

Dr. Despina Drivakou

Psychologist Msc, phd.c.

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 September 2022 in Metabolites
Verified
Journal Article
Open access
PDF file
EZEvangelia Zaromytidou
Evangelia Zaromytidou
TKTheocharis Koufakis
Theocharis Koufakis
GDGeorgios Dimakopoulos
Georgios Dimakopoulos
Despina DrivakouDespina Drivakou
Despina Drivakou
SKStavroula Konstantinidou
Stavroula Konstantinidou
KKKalliopi Kotsa
Kalliopi Kotsa
Older people are prone to frailness, present poor adherence to pharmacotherapy, and often have adverse drug effects. Therefore, it is important to develop effective and safe interventions to mitigate the burden of anxiety and depression disorders in this population. The aim of this study was to investigate the effect of vitamin D supplementation on the anxiety and depression status of elderly people with prediabetes. Participants were randomly assigned a weekly dose of vitamin D3 of 25,000 IU (n = 45, mean age 73.10 ± 7.16 years) or nothing (n = 45, mean age 74.03 ± 7.64 years), in addition to suggested lifestyle measures. The State-Trait Anxiety Inventory subscales (STAI-T and STAI-S) and the Patient Health Questionnaire-9 (PHQ-9) were used to evaluate anxiety and depression levels, respectively, at baseline, 6, and 12 months. A total of 92.68% of the participants in the vitamin D group and 97.14% of the controls exhibited vitamin D deficiency (<20 ng/mL) at baseline. Mean STAI-T scores were lower in supplemented individuals than in the control group at 6 (38.02 ± 9.03 vs. 43.91 ± 7.18, p = 0.003) and 12 months (32.35 ± 7.77 vs. 44.97 ± 7.78, p < 0.001). The same pattern was evident for STAI-S scores at 6 (37.11 ± 7.88 vs. 43.20 ± 9.33, p = 0.003) and 12 months (32.59 ± 6.45 vs. 44.60 ± 9.53, p < 0.001). Supplemented participants demonstrated lower mean PHQ-9 scores compared to controls at 6 (15.69 ± 6.15 vs. 19.77 ± 8.96, p = 0.021) and 12 months (13.52 ± 5.01 vs. 20.20 ± 8.67, p < 0.001). Participants with deficiency and insufficiency at baseline experienced equal benefits of supplementation in terms of anxiety and depression scores. In conclusion, in a high-risk population, a weekly vitamin D supplementation scheme was effective in alleviating anxiety and depression symptoms. More studies are needed to elucidate the relevant mechanisms.

2 June 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
Despina DrivakouDespina Drivakou
Despina Drivakou
NRNikolaos Roussos
Nikolaos Roussos
ITIakovos Theodoulidis
Iakovos Theodoulidis
KDKonstadinos Dinas
Konstadinos Dinas
TMThemistoklis Mikos
Themistoklis Mikos
MKMary Kosmidis
Mary Kosmidis
Stress urinary incontinence (SUI) is conventionally viewed as a peripheral mechanical disorder, but the growing evidence has highlighted the significant psychological burden. This kind of narrative integrative review has examined SUI through a chronic stress framework and this has linked clinical outcomes with epigenetic and neuroendocrine mechanisms. Evidence has suggested that SUI-related experiences can activate the HPA axis and contribute to allostatic load, and might also induce an epigenetic alteration in stress-related genes such as FKBP5 and NR3C1. These are linked with consistent effective symptoms even after the treatment. In addition to this, the review has highlighted the important function of anticipatory anxiety, behavioural avoidance, and social evaluative threat in the sustenance of chronic stress exposure among individuals who have SUI. These psychosocial mechanisms have interacted dynamically with other biological processes, and it has reinforced a feedback loop which has contributed to psychological vulnerability and persistence. The evidence has highlighted the heterogeneity of patient outcomes, and it has suggested the presence of distinctive vulnerability and resilience profiles which are shaped by individualistic differences in the responsivity to stress and coping strategies. Collectively, this thorough integrative perspective has highlighted the requirement of moving beyond solely biomedical models towards a more interdisciplinary approach that can incorporate biological and psychological assessment. Such a framework has crucial implications for targeted interventions, early identification, and the development of more exhaustive management strategies for SUI. This review has proposed a stress-epigenetic model which integrates psychosocial and biological pathways, thereby offering new types of insights into SUI as a condition with translational and systemic relevance to psychiatry.

25 November 2025 in Cureus
Verified
Journal Article
Open access
Despina DrivakouDespina Drivakou
Despina Drivakou
TITheodoulidis Iakovos
Theodoulidis Iakovos
RNRoussos Nikolaos
Roussos Nikolaos
TSTsiapakidou Sofia
Tsiapakidou Sofia
PKPantazis Konstadinos
Pantazis Konstadinos
MKMary H. Kosmidis
Mary H. Kosmidis
This article has been corrected to include authors in author positions 2-8 as they were originally omitted by the submitting author. All authors have agreed to these changes.

15 September 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
Despina DrivakouDespina Drivakou
Despina Drivakou
NRNikolaos Roussos
Nikolaos Roussos
ITIakovos Theodoulidis
Iakovos Theodoulidis
KDKonstantinos Dinas
Konstantinos Dinas
TMThemistoklis Mikos
Themistoklis Mikos
MKMary Kosmidis
Mary Kosmidis
Stress urinary incontinence (SUI) is conventionally viewed as a peripheral mechanical disorder, yet its psychological burden suggests that a broader biopsychosocial interpretation may be warranted. This perspective considers whether recurrent leakage, anticipatory anxiety, behavioural avoidance, and social evaluative threat may allow SUI to function as a chronic psychosocial stressor. It integrates clinical observations with established concepts in stress physiology, hypothalamic–pituitary–adrenal (HPA) axis regulation, allostatic load, inflammation, and stress-related epigenetic mechanisms, including FKBP5 and NR3C1. Direct molecular evidence in SUI populations remains limited; therefore, the proposed links are presented as a hypothesis-generating framework rather than as established causal pathways. The framework further emphasises the heterogeneity of patient outcomes. Differences in perceived symptom burden, coping, stress responsivity, prior vulnerability, and resilience may help explain why psychological symptoms improve after treatment in some individuals yet persist in others. These interacting psychosocial and biological processes may reinforce a feedback loop between symptom-related threat, sustained stress activation, and affective vulnerability. By moving beyond a solely mechanical model, this perspective supports a more interdisciplinary approach combining urogynecological and psychological assessment. The proposed stress-epigenetic framework is intended to guide future longitudinal and biomarker-informed research and to encourage more integrated approaches to the prevention and management of psychological burden in SUI.